Company news
Jade Biosciences, Inc. news in 2021
Jade Biosciences, Inc.'s news releases, calls and decks from 2021, newest first.
Aerovate Therapeutics Announces Initiation of IMPAHCT Phase 2b/Phase 3 Trial of AV-101 In Pulmonary Arterial Hypertension
December 14, 2021
Aerovate Therapeutics Announces Third Quarter 2021 Financial Results
November 14, 2021
Aerovate Therapeutics Announces Its Addition to the Russell 2000® Index
September 16, 2021
Aerovate Therapeutics Announces Second Quarter 2021 Financial Results
August 15, 2021
Aerovate Therapeutics Appoints Allison Dorval To Its Board of Directors
July 18, 2021
Aerovate Therapeutics Announces Closing of Initial Public Offering with Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
July 1, 2021
Aerovate Therapeutics Announces Pricing of Upsized Initial Public Offering
June 28, 2021